El Grupo de Investigación Traslacional en Enfermedades Neurológicas pone a disposición de las personas interesadas su plataforma SIMOA HD-X

El Grupo de Investigación Traslacional en Enfermedades Neurológicas pone a disposición de las personas interesadas su plataforma SIMOA HD-X

La Plataforma de Biomarcadores en Fluidos Biológicos (SIMOA HD-X) se encuentra ya disponible en la página web del IDIS Santiago de Compostela, 17 de enero de 2025.- El Grupo de Investigación Traslacional en Enfermedades Neurológicas (ITEN) que dirige el Dr. José María...
The scientific director of the Health Research Institute of Santiago de Compostela (IDIS), Mª Luz Couce Pico, receives the XXIII Nóvoa Santos Award

The scientific director of the Health Research Institute of Santiago de Compostela (IDIS), Mª Luz Couce Pico, receives the XXIII Nóvoa Santos Award

On April 26, 2024, Santiago de Compostela.- The scientific director of the Health Research Institute of Santiago de Compostela (IDIS), Mª Luz Couce Pico, was honored with the XXIII Nóvoa Santos Award by the association AMG (Association of Galician Doctors). The award...
DIVERSA Biotechnologies has concluded its capital expansion with Sémola Tech Ventures SL, Volsunga SL, Janus Projects SL, and UNIRISCO.

DIVERSA Biotechnologies has concluded its capital expansion with Sémola Tech Ventures SL, Volsunga SL, Janus Projects SL, and UNIRISCO.

Santiago de Compostela, April 24, 2024.- DIVERSA Technologies SL, a company aiming to make an impact across the entire value chain in the field of biotechnology and nanomedicine, closed its capital expansion. Their focus is on driving the development of innovative...
Privacy overview

This website uses cookies so that we can offer you the best possible user experience. The cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team to understand which sections of the website you find most interesting and useful.